GlassScriptPhysician profile
Anthony R Mann
NPI 1801150511
$4,036.28
in general payments reported to CMS, 2019-2025
26 companies · $1,432 in 2025
The $1,432 reported for 2025 was more than what 93% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $551 · 2022: $750 · 2023: $604 · 2024: $700 · 2025: $1,432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,251 · Travel and Lodging: $484.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,251.25 |
| Travel and Lodging | $483.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $841.58 | 2025 | |
| Depuy Synthes Sales INC. | $763.75 | 2021-2025 | Orthovisc, Monovisc, Inhance |
| Stryker Corporation | $423.75 | 2022-2025 | Aequalis Ascend Flex, Na, Flexible Guide Pin (Stryker Acl Versitomic) |
| Zimmer Biomet Holdings, INC. | $411.44 | 2021-2024 | |
| Ferring Pharmaceuticals INC. | $274.29 | 2021-2024 | Euflexxa |
| Conetic Solutions, INC. | $256.51 | 2022-2025 | |
| Baxter Healthcare | $231.80 | 2022-2025 | Floseal |
| Smith+Nephew, INC. | $198.59 | 2022-2024 | Pico, Pico 14, Renasys Go V2 Home |
| Kerecis Limited | $139.19 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Medtronic, INC. | $83.55 | 2021-2024 | Aquamantys(Tm) |
| Bioventus LLC | $65.84 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $55.88 | 2022-2023 | Seglentis |
| Biocomposites INC | $33.76 | 2024 | |
| Amgen INC. | $27.11 | 2022 | |
| Sanara Medtech INC. | $25.70 | 2024 | Celleraterx |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $24.61 | 2022 | |
| Treace Medical Concepts, INC. | $24.01 | 2022 | |
| Spr Therapeutics, INC | $23.96 | 2022 | |
| Osteoremedies, LLC | $21.46 | 2024 | Biobrush, Remedy Spectrum Gv Spacer, Remedy Spacer |
| Integra Lifesciences Corporation | $21.24 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Pacira Pharmaceuticals Incorporated | $19.56 | 2022 | |
| Heron Therapeutics, INC. | $16.84 | 2024 | Zynrelef |
| Ultragenyx Pharmaceutical INC. | $15.99 | 2022 | |
| Axsome Therapeutics, INC. | $12.73 | 2022 | |
| Idorsia Pharmaceuticals US INC | $11.70 | 2022 | |
| Horizon Therapeutics Plc | $11.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.